CEL-SCI Corporation (CVM), headquartered in Vienna, Virginia, is a pioneering biotechnology firm dedicated to advancing immunotherapy solutions for cancer and infectious diseases. Its lead candidate, Multikine, represents a novel approach by leveraging the body's immune response to target tumors, showcasing substantial potential in the oncology sector. With a strong and diverse pipeline addressing significant unmet medical needs, CEL-SCI is well-positioned to disrupt the biopharmaceutical landscape, appealing to institutional investors seeking to back innovative healthcare advancements. Show more
Location: 8229 BOONE BOULEVARD, VIENNA, VA, UNITED STATES, 22182, Vienna, VA, 22182, USA | Website: https://cel-sci.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
48.77M
52 Wk Range
$1.98 - $16.20
Previous Close
$5.87
Open
$5.94
Volume
82,770
Day Range
$5.43 - $6.01
Enterprise Value
47.79M
Cash
10.95B
Avg Qtr Burn
-4.671M
Insider Ownership
8.17%
Institutional Own.
10.55%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Multikine (Leukocyte Interleukin) Details Head and neck cancer, Cancer, Human papillomavirus, Solid tumor/s | Phase 3 Initiation |